Cargando…
The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification
OBJECTIVES: Although patients with grade I and II endometrioid endometrial adenocarcinoma (EEA) are considered with good prognosis, among them 15%–25% died in 5 years. It is still unknown whether integrating estrogen receptor (ER) and progesterone receptor (PR) into clinical risk stratification can...
Autores principales: | Guan, Jun, Xie, Liying, Luo, Xuezhen, Yang, Bingyi, Zhang, Hongwei, Zhu, Qin, Chen, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304404/ https://www.ncbi.nlm.nih.gov/pubmed/30479097 http://dx.doi.org/10.3802/jgo.2019.30.e13 |
Ejemplares similares
-
The expression of stanniocalcin-1, estrogen receptor and progesterone receptor in endometrioid endometrial cancer
por: Erkılınç, Gamze, et al.
Publicado: (2023) -
Estrogen/Progesterone Receptor Loss, CTNNB1 and KRAS Mutations Are Associated With Local Recurrence or Distant Metastasis in Low-Grade Endometrial Endometrioid Carcinoma
por: Chibbar, Rajni, et al.
Publicado: (2023) -
Endometrial Progesterone and Estrogen Receptors in Relation to Hormonal Levels in Women with Unexplained Recurrent Miscarriage
por: Gomaa, Ihab Adel, et al.
Publicado: (2023) -
Distribution of estrogen and progesterone receptors isoforms in endometrial cancer
por: Kreizman-Shefer, Hila, et al.
Publicado: (2014) -
Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer
por: Wang, Caifeng, et al.
Publicado: (2020)